Wayne Levin
Papers
1
Total Citations
26
H-Index
1
About
Wayne Levin is a biochemist whose research centers on the mechanistic roles of heparanase in cancer metastasis and inflammation. His major contributions include pioneering high-throughput screening methodologies that enable rapid, quantitative measurement of heparanase enzymatic activity—a key enzyme implicated in tumor invasion and inflammatory disease. His most cited work, "High-throughput methods for measuring heparanase activity and screening potential antimetastatic and anti-inflammatory agents" (2004, 26 citations), established a foundational platform for identifying small-molecule inhibitors of heparanase, opening new avenues for developing targeted therapies against metastatic cancers and chronic inflammatory conditions. This methodological innovation has been instrumental in bridging basic enzymology with drug discovery, allowing researchers to efficiently screen compound libraries for potential antimetastatic agents. Levin’s work is notable for its translational impact, providing tools that have been adopted by laboratories worldwide to explore heparanase inhibition as a therapeutic strategy. His research continues to influence the design of high-throughput assays in glycobiology, underscoring his role in advancing both fundamental understanding and clinical applications of heparanase biology.
Research Focus
Key Achievements
Top Papers
- 1